Amato de Paulis Selected Research

Amato de Paulis Research Topics

Disease

12	Inflammation (Inflammations) 01/2022 - 11/2006
7	Neoplasms (Cancer) 12/2021 - 08/2013
4	Rheumatoid Arthritis 01/2021 - 12/2018
3	Arthritis (Polyarthritis) 12/2021 - 09/2015
3	Systemic Scleroderma (Systemic Sclerosis) 01/2020 - 01/2017
2	Eosinophilia 06/2021 - 04/2021
2	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2021 - 12/2015
2	Common Variable Immunodeficiency 10/2020 - 01/2019
2	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 01/2017
1	Atopic Dermatitis (Atopic Eczema) 01/2022
1	Chronic Urticaria 01/2022
1	Hodgkin Disease (Hodgkin's Disease) 12/2021
1	Lupus Nephritis 11/2021
1	Hypertension (High Blood Pressure) 11/2021
1	Proteinuria 11/2021
1	Systemic Mastocytosis 08/2021
1	Mastocytosis 08/2021
1	Asthma (Bronchial Asthma) 06/2021
1	Vasculitis (Vasculitides) 06/2021
1	Polyps 06/2021
1	Urticaria (Hives) 04/2021
1	Angioedema 04/2021
1	Weight Gain 04/2021
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 02/2021
1	Hemorrhage 02/2021
1	Thrombosis (Thrombus) 02/2021
1	Atherosclerosis 10/2020
1	Insulin Resistance 10/2020
1	Heart Failure 06/2020
1	Synovitis 01/2020
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2020
1	Thyroid Neoplasms (Thyroid Cancer) 08/2019
1	Hyperplasia 01/2019
1	Cytopenia 01/2019
1	Reinfection 01/2019
1	Infections 01/2019
1	Primary Immunodeficiency Diseases 01/2019
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2019
1	Thyroiditis 01/2017
1	Stomach Neoplasms (Stomach Cancer) 01/2017
1	Hypothyroidism 01/2017
1	Neoplasm Metastasis (Metastasis) 11/2016
1	Fibrosis (Cirrhosis) 06/2015

Drug/Important Bio-Agent (IBA)

5	AutoantibodiesIBA 01/2022 - 01/2017
4	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 01/2021 - 12/2015
3	Immunoglobulin G (IgG)IBA 01/2022 - 01/2019
3	CytokinesIBA 01/2022 - 08/2019
3	Vascular Endothelial Growth FactorsIBA 08/2021 - 11/2006
3	Immunoglobulins (Immunoglobulin)IBA 10/2020 - 12/2003
3	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2020 - 01/2017
3	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2018 - 08/2013
2	Immunoglobulin E (IgE)IBA 01/2022 - 12/2021
2	belimumabIBA 11/2021 - 01/2020
2	AngiopoietinsIBA 08/2021 - 06/2020
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2021 - 11/2006
2	Monoclonal AntibodiesIBA 06/2021 - 08/2019
2	Pattern Recognition ReceptorsIBA 01/2021 - 12/2015
2	Pharmaceutical PreparationsIBA 01/2020 - 08/2013
2	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2019 - 01/2018
2	Biological ProductsIBA 01/2019 - 12/2003
2	Proteins (Proteins, Gene)FDA Link 12/2018 - 12/2003
2	LipoxygenasesIBA 01/2018 - 01/2017
2	VitronectinIBA 06/2015 - 08/2013
1	anti-IgE antibodiesIBA 01/2022
1	NivolumabIBA 12/2021
1	CreatinineIBA 11/2021
1	Vascular Endothelial Growth Factor CIBA 08/2021
1	Codon (Codons)IBA 08/2021
1	Vascular Endothelial Growth Factor DIBA 08/2021
1	mepolizumabIBA 06/2021
1	Prednisone (Sone)FDA LinkGeneric 06/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2021
1	Vitamin K FDA Link 02/2021
1	Antiphospholipid AntibodiesIBA 02/2021
1	Secretory Phospholipases A2IBA 06/2020
1	LipidsIBA 01/2020
1	Eicosapentaenoic AcidIBA 01/2020
1	Antirheumatic Agents (DMARD)IBA 01/2020
1	Docosahexaenoic AcidsIBA 01/2020
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2020
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 08/2019
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 08/2019
1	ChemokinesIBA 08/2019
1	Programmed Cell Death 1 ReceptorIBA 08/2019
1	Immune Checkpoint InhibitorsIBA 08/2019
1	CTLA-4 AntigenIBA 08/2019
1	Janus KinasesIBA 01/2019
1	Immunoglobulin A (IgA)IBA 01/2019
1	Rituximab (Mabthera)FDA Link 01/2019
1	Janus Kinase InhibitorsIBA 01/2019
1	Interleukin-27 (Interleukin 27)IBA 12/2018
1	AntigensIBA 12/2018
1	AntibodiesIBA 12/2018
1	EnzymesIBA 01/2018
1	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2017
1	PlasminogenIBA 11/2016
1	Interleukin-33IBA 09/2015
1	Peptides (Polypeptides)IBA 06/2015

Therapy/Procedure

4	Therapeutics 11/2021 - 01/2019
1	Aftercare (After-Treatment) 01/2020